Insulet Corporation (NASDAQ:PODD) shares have risen on a wave of bullish analyst actions and favorable coverage. Here are the main drivers:
Positive Sentiment:
Leerink Partners raised its Q3 2025 EPS estimate to $1.12 (from $1.08), reflecting stronger-than-expected profitability.
Leerink Partnrs Brokers Raise Earnings Estimates for Insulet
Positive Sentiment:
Wall Street Zen upgraded the stock to a “Buy,” signaling growing confidence in Insulet’s growth trajectory.
Wall Street Zen Upgrades Insulet (NASDAQ:PODD) to "Buy"
Positive Sentiment:
Wells Fargo & Company set a new $350.00 price target, suggesting upside from current levels.
Insulet (NASDAQ:PODD) Given New $350.00 Price Target at Wells Fargo & Company
Positive Sentiment:
Canaccord Genuity lifted its target from $331.00 to $353.00 and maintained a “Buy” rating.
Canaccord Genuity Group Issues Positive Forecast for Insulet (NASDAQ:PODD) Stock Price
Positive Sentiment:
Royal Bank of Canada raised its target to $350.00 and reiterated an “Outperform” rating.
Insulet (NASDAQ:PODD) Price Target Raised to $350.00
Positive Sentiment:
GuruFocus highlighted Insulet’s strong financial metrics and competitive strengths in “Insulet Corp (PODD)’s Winning Formula.”
Insulet Corp (PODD)'s Winning Formula: Financial Metrics and Competitive Strengths
Positive Sentiment:
Zacks named Insulet a top long-term growth stock, underscoring solid style scores.
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
Neutral Sentiment:
Short interest data showed no meaningful change, with days-to-cover remaining at 0.0, indicating minimal bearish bets against the shares.
Investors will likely keep an eye on upcoming earnings results and any shifts in short interest for further direction.
Posted 1h ago
AI Generated. May Contain Errors.